Asthma types of asthma
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding the Types of Asthma: Phenotypes and Endotypes
Asthma is a chronic inflammatory disease of the airways, characterized by a high degree of heterogeneity in its clinical presentation and underlying mechanisms. This complexity has led to the identification of various asthma phenotypes and endotypes, which are crucial for personalized treatment approaches.
Asthma Phenotypes: Clinical Characteristics
Early-Onset Allergic Asthma
Early-onset allergic asthma typically begins in childhood and is associated with a strong allergic component. Patients often exhibit elevated levels of immunoglobulin E (IgE) and eosinophils, and they respond well to corticosteroids and other anti-inflammatory treatments .
Early-Onset Allergic Moderate-to-Severe Remodeled Asthma
This phenotype is a more severe form of early-onset allergic asthma, characterized by significant airway remodeling. Patients may experience persistent symptoms and frequent exacerbations despite standard treatments.
Late-Onset Nonallergic Eosinophilic Asthma
This type of asthma usually manifests in adulthood and is not associated with allergies. It is characterized by high levels of eosinophils in the airways, and patients often respond well to biologic therapies targeting eosinophilic inflammation .
Late-Onset Nonallergic Noneosinophilic Asthma
Patients with this phenotype do not exhibit elevated eosinophil levels and often have a poor response to corticosteroids. This type of asthma is frequently associated with other conditions such as obesity and may involve neutrophilic inflammation .
Asthma Endotypes: Underlying Mechanisms
Type 2 (T2)-High Asthma
T2-high asthma is driven by type 2 cytokines such as interleukin-4 (IL-4), IL-5, and IL-13, which promote eosinophilia, mucus overproduction, and bronchial hyperresponsiveness (BHR). This endotype is commonly associated with allergic asthma and responds well to biologic therapies targeting these cytokines .
Type 2 (T2)-Low Asthma
T2-low asthma is less understood and is characterized by the absence of type 2 cytokine signatures. It is often associated with neutrophilic inflammation, obesity, and a poor response to corticosteroids. This endotype may involve other cytokines such as IL-17 and is linked to environmental factors like pollution and infections .
Immunologic Mechanisms in Asthma
Asthma involves complex interactions between the innate and adaptive immune systems. In T2-high asthma, Th2 cells and type 2 innate lymphoid cells (ILC2s) play a significant role by producing cytokines that drive eosinophilic inflammation. In contrast, T2-low asthma may involve Th17 cells and type 3 ILCs, which contribute to neutrophilic inflammation .
Clinical Implications and Future Directions
Understanding the diverse phenotypes and endotypes of asthma is essential for developing targeted therapies. Biologic agents targeting specific cytokines have shown promise in treating T2-high asthma, while research is ongoing to find effective treatments for T2-low asthma. Personalized medicine approaches, guided by biomarkers and clinical characteristics, are the future of asthma management .
Conclusion
Asthma is a multifaceted disease with various phenotypes and endotypes, each with distinct clinical and immunologic characteristics. Recognizing these subtypes is crucial for effective treatment and management, paving the way for precision medicine in asthma care.
Sources and full results
Most relevant research papers on this topic